Journal
/
/
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Journal JoVE
Recherche en cancérologie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Recherche en cancérologie
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
DOI:

06:08 min

June 02, 2023

, , , , , , , , ,

Chapitres

  • 00:04Introduction
  • 01:03Tumor Transplantation and Preservation
  • 02:49Resuscitation of Patient-Derived Xenograft (PDX) Model Tumors
  • 03:57Results: Tumor Growth Assessment & Effect of Lenvatinib and Cisplatin on PDX Model Tumors
  • 05:28Conclusion

Summary

Traduction automatique

The present protocol establishes and characterizes a patient-derived xenograft (PDX) model of anaplastic thyroid carcinoma (ATC) and head and neck squamous cell carcinoma (HNSCC), as PDX models are rapidly becoming the standard in the field of translational oncology.

Vidéos Connexes

Read Article